Abstract
Nanotechnology has made great strides within the last two decades in developing novel methods for drug delivery and vaccine design. These include a variety of nanoparticles (both conjugated and enclosing). These have been deployed to treat viruses, MDR bacteria, and various cancers. Recently they have been used to develop new vaccines in record time for the SARS-Corona-2 virus. On December 8, 2020 the United Kingdom began vaccinations with the Pfizer BioNTech vaccine; this was followed less than a week later in the United States. However, new and more efficient drug carriers and vaccines are not in themselves sufficient for the development of sustainable antimicrobial technologies. They are simply tools, and tools without correct theory cannot achieve the desired end. How we more effectively deploy these new methods will be the subject of this chapter.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
